A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.

Chemotherapy

Volumn 48, Issue 4, 2002, Pages 211-216

  Bazarbashi, Shouki ^a   Rahal, Mohammed ^a   Raja, Madras A ^a   El Weshi, Amr ^a   Pai, Chandrashekar ^a   Ezzat, Adnan ^a   Ajarim, Dahish ^a   Memon, Mohammed ^a   Al Fadda, Mohammed ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; ESOPHAGUS TUMOR; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; LEUKOPENIA; MALE; MIDDLE AGED; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0036728217     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063870     Document Type: Article

References (0)